Difference between revisions of "Gautret P, et al, Int J Antimicrob Agents (2020), cited as Ref 82 in DOI:10.1007/s11886-020-01292-3 (Q10591)"
Jump to navigation
Jump to search
(Created claim: Published In Name String (P102): Int J Antimicrob Agents, #quickstatements; #temporary_batch_1592505200825) |
(Added link to [sliswiki]: Gautret P, et al, Int J Antimicrob Agents (2020), cited as Ref 82 in DOI:10.1007/s11886-020-01292-3, #quickstatements; #temporary_batch_1592946843269) |
||
| links / sliswiki / name | links / sliswiki / name | ||
| + | |||
Latest revision as of 21:15, 23 June 2020
Cited in: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response" Research article published in Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Gautret P, et al, Int J Antimicrob Agents (2020), cited as Ref 82 in DOI:10.1007/s11886-020-01292-3
|
Cited in: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response" Research article published in Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32.
|
Statements
Q10356 (Deleted Item)
0 references
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial;105949. (English)
0 references
Gautret P
0 references
Lagier J-C
0 references
Parola P
0 references
Hoang VT
0 references
Meddeb L
0 references
Mailhe M
0 references
2020
0 references
Int J Antimicrob Agents
0 references
